June 30, 2022
Life Sciences
  • Pfizer and BioNTech announced they will initiate clinical trials of pan-coronavirus vaccines in the second half of the year. The company said it wants to provide “durable variant protection.” Universal vaccines have been studied with limited success for years, but they are gaining renewed investment and research interest. (Article here)